lung cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Age 18-75 years; 2) ECOG/PS score of grade 0-1 and expected survival = 3 months; 3) Non-small cell lung cancer AJCC lung cancer staging of stage IIIB-IV or small cell lung cancer staging of extensive stage; 4) Those with low or negative PD-L1 expression (TPS 1cm) or lymph node short diameter 1.5 cm; 9) Signed an informed consent form to voluntarily participate in this study.
Exclusion criteria
Exclusion criteria: 1) Combined with other primary malignant tumors; 2) Those who have contraindications to immunotherapy after basic evaluation of immunotherapy pre-treatment; 3) Those who have autoimmune system diseases or need long-term treatment with systemic steroids or immunosuppressants; 3) Those who have autoimmune system diseases or need long-term treatment with systemic steroids or immunosuppressants; 4) Those who are combined with serious and uncontrolled primary diseases of the heart cerebrovascular system liver kidney and hematopoietic system; 5) Those with metal allergy or severe fear of needles; 6) Those who are pregnant or breastfeeding; 7) Those with mental disorders or intellectual or speech impairment that prevents them from cooperating to complete the assessment; 8) Those with active severe infectious or inflammatory diseases; 9) Those who have received acupuncture treatment or other clinical trials within 1 month prior to randomization; 10) Those who are unable to take food by mouth; 11) Persons with concomitant illnesses that in the judgment of the investigator seriously jeopardize the safety of the participant or interfere with the completion of the study or who are deemed to have other reasons for being unsuitable for enrollment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Functional Assessment of Anorexia/Cachexia Therapy - Anorexia/Cachexia Subscale;Visual Analog Score for loss of appetite; | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient Health Questionnaire-9;Generalized Anxiety Disorder-7;Lung Cancer Symptom Scale;Eastern Cooperative Oncology Group Performance Status;Insomnia Severity Index;Adverse Event;Disease Control Rate;weight;Objective Response Rate; | — |
Countries
China
Contacts
Guang'anmen Hospital Chinese Academy of Traditional Chinese Medicine